Build Generational Wealth with
AlphaMadera's AI-Driven Investment Intelligence

Institutional-grade analytics, real-time data, and AI research tools — built for investors who think in decades, not days.

Ask Compass anything about the market — earnings, filings, or strategy — in plain English.

Real-time institutional data AI that reads filings & transcripts Built for decades, not days
Try Compass — AI Research → Run the Screener
or search any ticker above
// Global Equity Tape
Dow Jones ^DJI
53,885.10
▼ -0.85% -464.02
S&P 500 ^GSPC
7,711.38
▼ -0.16% -12.17
Nasdaq Composite ^IXIC
26,348.35
▼ -0.06% -15.09
Nasdaq 100 ^NDX
29,373.33
▼ -0.39% -114.46
Russell 2000 ^RUT
3,001.55
▼ -0.58% -17.64
NYSE Composite ^NYA
24,452.39
▼ -0.25% -61.43
S&P 500 Equal Weight ^SPXEW
8,852.65
▼ -0.55% -48.76
Wilshire 5000 ^W5000
68,217.20
▼ -1.03% -711.12
NYSE American Composite ^XAX
8,467.94
▲ +0.31% +26.32
STOXX Europe 600 ^STOXX50E
6,502.56
▲ +0.39% +25.58
Editorial illustration: PRIMARY SUBJECT — this editorial photo illustrates a story about Moderna, Inc., a Biotechnology company in the Healthcar
AlphaBlog

Moderna’s Flu Win Reopens the mRNA Question

The first FDA approval of an mRNA flu vaccine gives Moderna a real regulatory win beyond COVID. The market implication is larger than one stock: platform biotech now has to prove it can be a business, not just a technology demo.

Read more →

Market News

Werner's Stock Fell On Good Results, Potential Sign Of Overvaluation

Werner's Stock Fell On Good Results, Potential Sign Of Overvaluation

Werner Enterprises delivered strong 2Q26 results, with 24% revenue growth and significant operating margin expansion, signaling a turning trucking cycle. WERN's valuation remains unattractive; even with a robust recovery, the stock trades at 11–12x optimistic earnings, limiting upside while downside risk persists. Capital allocation is constrained; underinvestment and rising capex needs will limit shareholder distributions and require further leveraging of the balance sheet.

Aug 06, 2026 02:31 PM • seekingalpha.com

Stock News

Here's What Key Metrics Tell Us About Warby Parker (WRBY) Q2 Earnings

The headline numbers for Warby Parker (WRBY) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

WRBY $26.96 (-2.31, -7.89%) ▼
Aug 06, 2026 07:31 PM • zacks.com

Kinetik Holdings: Better Q2 Earnings, Still Not Cheap

Kinetik remains a quality midstream story, supported by strong assets, dividends, and the Kings Landing II FID catalyst. Q2 saw adjusted EBITDA rise to $280.8M and dividend coverage improve to 1.47x, but processed gas volumes stayed flat YoY. Kings Landing II FID increases long-term growth optionality, yet introduces capex and execution risks, with cash flow impact expected in 2028.

KNTK $50.17 (+1.82, +3.76%) ▲
Aug 06, 2026 07:30 PM • seekingalpha.com

Enovis Corporation (ENOV) Q2 2026 Earnings Call Transcript

Enovis Corporation (ENOV) Q2 2026 Earnings Call Transcript

ENOV $26.31 (-3.87, -12.82%) ▼
Aug 06, 2026 07:24 PM • seekingalpha.com

Etsy: Efficiency Push And GMS Strength

Etsy remains a buy after a post-earnings dip, with strong Q2 results and a healthy guidance raise supporting the investment thesis. ETSY's 12% headcount reduction and $2B buyback authorization signal a commitment to operational efficiency and capital return. Standalone Etsy GMS accelerated to 7.5% y/y growth, aided by higher average order values and increased active buyers.

ETSY $82.26 (-3.60, -4.19%) ▼
Aug 06, 2026 07:16 PM • seekingalpha.com

Sezzle Inc. (SEZL) Q2 2026 Earnings Call Transcript

Sezzle Inc. (SEZL) Q2 2026 Earnings Call Transcript

SEZL $178.53 (+4.13, +2.37%) ▲
Aug 06, 2026 07:14 PM • seekingalpha.com

ICF International Q2 Earnings Call Highlights

ICF International NASDAQ: ICFI reported second-quarter 2026 revenue that was essentially unchanged from a year earlier as growth in commercial, international and other non-federal markets offset a year-over-year decline in federal revenue. Management said the company remains on track to return to year-over-year revenue growth in the second half of 2026 and reaffirmed its full-year guidance.

ICFI $85.31 (+0.50, +0.59%) ▲
Aug 06, 2026 07:04 PM • marketbeat.com

ICU Medical Q2 Earnings Call Highlights

ICU Medical NASDAQ: ICUI reported second-quarter revenue of $548 million, up 6% organically and 1% on a reported basis, as growth in its consumables and infusion systems businesses helped offset continued pressure in Vital Care and the effects of the IV Solutions joint venture deconsolidation.

ICUI $166.37 (-0.03, -0.02%) ▼
Aug 06, 2026 07:04 PM • marketbeat.com

Innodata Q2 Earnings Call Highlights

Innodata NASDAQ: INOD reported record second-quarter results for 2026, with revenue, adjusted gross profit, adjusted EBITDA and cash reaching new highs as the company continued to expand its work with AI model developers and large technology customers.

INOD $65.48 (-3.89, -5.61%) ▼
Aug 06, 2026 07:04 PM • marketbeat.com

iRhythm Technologies Q2 Earnings Call Highlights

iRhythm Technologies NASDAQ: IRTC reported second-quarter revenue growth of 20.1% and raised its full-year outlook, while announcing an agreement to acquire VitalConnect to broaden its cardiac monitoring portfolio and enter additional patient-monitoring markets.

IRTC $128.12 (+3.62, +2.91%) ▲
Aug 06, 2026 07:04 PM • marketbeat.com

VSE Corporation (VSEC) Q2 2026 Earnings Call Transcript

VSE Corporation (VSEC) Q2 2026 Earnings Call Transcript

VSEC $225.45 (+9.70, +4.50%) ▲
Aug 06, 2026 07:04 PM • seekingalpha.com